Thursday, April 24, 2014
Publication and contact
Assays & screens
Ex vivo model of HIV latency to screen latency-reversing
An ex vivo model of
latent HIV in patient T cells could help predict clinical efficacy of
latency-reversing agents. In a coculture of
T cells from patients latently infected with HIV and healthy controls,
latency-reversing compounds previously shown to be effective in vitro
failed to induce spreading of the virus to noninfected cells, indicating that
they do not reverse viral latency ex vivo. In latently infected cells
from patients on antiretroviral therapy, all tested compounds failed to
reverse latency as measured by HIV mRNA transcription except bryostatin-1,
which is toxic in vivo. Next steps include identifying new agents or
combinations that reactivate latent HIV in patient cells.
Published online April 24, 2014
status not applicable
Bullen, C.K. et al. Nat.
Med.; published online March 23, 2014;
Contact: Robert F. Siliciano, The Johns Hopkins University
School of Medicine, Baltimore, Md.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]